Prudential Financial
SQZ

Prudential Financial’s SQZ Biotechnologies Company SQZ Stock Holding History

Prudential Financial’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,200
Closed -$10.9K – 2741
2023
Q2 		$10.9K Buy
+40,200
New +$22.8K ﹤0.01% 2608
2023
Q1 		– Sell
-11,450
Closed -$8.47K – 2693
2022
Q4 		$8.47K Hold
11,450
– – ﹤0.01% 2582
2022
Q3 		$26K Hold
11,450
– – ﹤0.01% 2618
2022
Q2 		$36K Buy
+11,450
New +$41.2K ﹤0.01% 2595

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Prudential Financial's SQZ Position: Q3 2023 in Review

Prudential Financial sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 40,200 shares — an estimated $10.9K sold.

Prudential Financial first reported a position in SQZ in Q2 2022 and held it in 4 quarters. The position peaked at $36K in Q2 2022. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Prudential Financial reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Prudential Financial sold 40,200 SQZ Biotechnologies Company shares in Q3 2023, an estimated $10.9K.
  • Prudential Financial first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 4 quarters.
  • Prudential Financial's SQZ Biotechnologies Company position peaked at $36K in Q2 2022.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.